Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers.
5 Jul, 2021 | 01:42h | UTCCommentaries: Expert reaction to review and analysis of observational studies on aspirin and cancer survival – Science Media Centre AND Major review of studies: Aspirin could cut risk of death in cancer patients by 20% – Cardiff University
“It is randomized trials that provide definitive evidence to consider changes to clinical practice. The results of this review provide impetus for cancer patients to consider participation in these trials” (from Science Media Centre)